Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4798)
All Articles published online
|
Publishing Process of This Article
|
Mar 25, 2024 (publication date) through Dec 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ndongo M, Nehemie LM, Coundoul B, Diouara AAM, Seck SM. Prevalence and outcomes of polycystic kidney disease in African populations: A systematic review. World J Nephrol 2024; 13(1): 90402 [PMID: 38596265 DOI: 10.5527/wjn.v13.i1.90402] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ndongo M, Nehemie LM, Coundoul B, Diouara AAM, Seck SM. Prevalence and outcomes of polycystic kidney disease in African populations: A systematic review. World J Nephrol 2024; 13(1): 90402 [PMID: 38596265 DOI: 10.5527/wjn.v13.i1.90402] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v13/i1/90402.htm |
| Number | Citing Articles |
| 1 |
Molla Asnake Kebede, Yewondwosen Tadesse Mengistu, Biruk Yacob Loge, Misikr Alemu Eshetu, Erkihun Pawlos Shash, Amenu Tolera Wirtu, Jickssa Mulissa Gemechu. Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of Personalized Medicine 2024; 14(9): 936 doi: 10.3390/jpm14090936
|
| 2 |
Lianxiang Duan, Ziyang Liu, Ling Chen, Yiqing Yang, Yenan Fan, Jie Chen, Jing Hu, Xuezhong Gong, Yue Guo. Efficacy and safety of Guben Tongluo formula in treating chronic kidney disease (stage G3): a multicenter randomized controlled clinical trial. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1691637
|
| 3 |
Weiwei Li, Lumiao Chen, Linsen Jiang, Zhijian Zhang, Kai Song. The prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in chronic kidney disease: a population-based analysis of NHANES data (1999–2018). Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1589173
|
| 4 |
Yumeng Li, Yousuf Waheed, Dong Sun. Exosomes and Renal Fibrosis: Diagnostic Value, Therapeutic Potential and Challenges. International Journal of Nanomedicine 2025; : 11267 doi: 10.2147/IJN.S529311
|
| 5 |
Yan-ni Wang, Xin Wu, Qi-yan Shan, Qiao Yang, Xiao-yong Yu, Jian-hua Yang, Hua Miao, Gang Cao, Ying-yong Zhao. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacologica Sinica 2025; 46(11): 2975 doi: 10.1038/s41401-025-01598-4
|
| 6 |
Hao-Yu Feng, Yi-Qi Wang, Jianhua Yang, Hua Miao, Ying-Yong Zhao, Xiaojuan Li. Anthraquinones from Rheum officinale Ameliorate Renal Fibrosis in Acute Kidney Injury and Chronic Kidney Disease. Drug Design, Development and Therapy 2025; : 5739 doi: 10.2147/DDDT.S521265
|